SPDR Gold Trust (GLD) Offering Possible 33.69% Return Over the Next 6 Calendar Days

SPDR Gold Trust's most recent trend suggests a bullish bias. One trading opportunity on SPDR Gold Trust is a Bull Put Spread using a strike $178.50 short put and a strike $173.50 long put offers a potential 33.69% return on risk over the next 6 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $178.50 by expiration. The full premium credit of $1.26 would be kept by the premium seller. The risk of $3.74 would be incurred if the stock dropped below the $173.50 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for SPDR Gold Trust is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for SPDR Gold Trust is bullish.

The RSI indicator is at 63.45 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for SPDR Gold Trust

Most Loved and Hated ETFs of 2020
Tue, 05 Jan 2021 17:15:05 +0000
We have highlighted ETFs that saw huge inflows and outflows during 2020.

Gold Down, Focus on Georgia Runoff Election
Tue, 05 Jan 2021 00:02:06 +0000
By Gina Lee

Gold Up, Shining Over Prospect of More COVID-19 Restrictive Measures
Sun, 03 Jan 2021 23:52:35 +0000
By Gina Lee

4 Top Stock Trades for Monday: AAPL, GLD, MRNA, CMI
Thu, 31 Dec 2020 20:52:21 +0000
With or without a great trading year, most of us are thankful to be wishing 2020 goodbye and welcoming 2021. That said, let’s look at a few top stock trades to ring in the new trading year on Monday Jan. 4. 
Top Stock Trades for Monday No. 1: Apple (AAPL)
Click to EnlargeSource: Chart courtesy of StockCharts.com
Let’s start with the biggest stock of them all: Apple (NASDAQ:AAPL). 
With its market capitalization of $2.25 trillion, Apple will likely always be an “all eyes on me” stock. Despite this, shares had been quite quiet over the past few months. Coming into December, I got bullish on this one and although it took a while to deliver, Apple really paid off well.InvestorPlace – Stock Market News, Stock Advice & Trading Tips
After hitting new all-time highs this week, shares have given us a “sell the news” reaction, which is not too surprising.
Now working on its third-straight daily decline, we have a nice reset down to the 10-day moving average. For active traders, that’s an opportunity. If support holds, we can look for a rotation back up the $138 resistance area. Above that, and the mid-$140s could be in play, with the 123.6% extension coming into play at $146.25.

Grading 10 of 2020's Hottest SPACs in Preparation for the New Year

I really don’t want to see Apple lose the $130 mark. Below $128, and uptrend support (blue line) puts the October high in play near $125, followed by a possible test of the 50-day and 100-day moving averages.

Top Stock Trades for Monday No. 2: SPDR Gold Trust ETF (GLD)
Click to EnlargeSource: Chart courtesy of TrendSpider
Gold has been an interesting play after the SPDR Gold Trust ETF (NYSEARCA:GLD) ripped hard off its test of the 50-week and 10-month moving averages. 
As a result, the GLD has rallied in four of the last five weeks, but it’s had a few false starts in that span. Now hitting its highest level since early November, bulls want to know if the yellow metal could have a bit more upside. 
I want to see a more potent rotation, preferably one that takes the GLD over the 21-week moving average and this pesky VWAP measure. Above that will put the November high in play up at $183.53. Over that, and the all-time high near $194.50 is technically possible, followed by $200. 
I prefer to wait for the rotation because these current measures — the 21-week moving average and VWAP — have been resistance. If that continues, we could reasonably see a dip down toward the $168 to $170 level. 
Perhaps it will be a buyable dip, but we’ll have to wait and see. 

Top Stock Trades for Monday No. 3: Moderna (MRNA)
Click to EnlargeSource: Chart courtesy of StockCharts.com
What a painful fall from grace we’ve seen with Moderna (NASDAQ:MRNA). Now down 40% from the all-time high on Dec. 1, Moderna has fallen for three straight weeks and in 12 of the past 16 trading sessions. 
Ouch. But we’re coming into some potential support.
Moderna is trading down into the 50-day moving average and filling the last of its major remaining gaps. Admittedly, it did this two days ago, as Moderna now spends the last trading day of the year probing this week’s low and threatening to fall even further. 
I want to see a failed breakdown here — referred to by some in the trading community as a “look below and fail” — where the stock briefly takes out support and the recent low, before reversing back to the upside.
If it’s a true breakdown, Moderna could be heading down toward $90 and the 100-day moving average. If it’s false breakdown, I want to see a move back up through the $115 area, followed by a test of the 161.8% extension near $120.50, then this week’s high of $122.88.

9 Long-Term Stocks for the Next Decade

Above this week’s high and the 10-day moving average, and MRNA stock could get back to its bullish ways of strong rallies.

Top Trades for Monday No. 4: Cummins (CMI)
Click to EnlargeSource: Chart courtesy of StockCharts.com
Last but certainly not least on our final top stock trades list of 2020 is Cummins (NYSE:CMI). Seldom discussed as a trading vehicle, this name keeps itching to move higher. 
The 10-week moving average had been support for months, but has wavered in December. That was no concern for longer-term bulls, as the 21-week moving average stepped in as support. 
Last week, CMI stock gave us a two-times weekly-up rotation (clearing the high from the last two weeks) and closed strong on the week. It promptly fell flat on Monday and Tuesday though, before recovering virtually all of those losses as the week draws to a close. 
In the first few weeks of 2021 (and preferably, the first few days), I want to see Cummins rotate over this week’s high at $228.68, opening the door to $238, then the all-time high near $245. 
On the date of publication, Bret Kenwell held a long position in AAPL and CMI.
Bret Kenwell is the manager and author of Future Blue Chips and is on Twitter @BretKenwell.
More From InvestorPlace

Why Everyone Is Investing in 5G All WRONG

Top Stock Picker Reveals His Next 1,000% Winner

Radical New Battery Could Dismantle Oil Markets

The post 4 Top Stock Trades for Monday: AAPL, GLD, MRNA, CMI appeared first on InvestorPlace.

Still Too Early to Buy Gold
Thu, 31 Dec 2020 14:21:29 +0000
The gold fund and futures contracts are grinding through corrections that could stretch through the first quarter of 2021.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.